S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0085 SEK Market Closed
Market Cap: 7.1m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

Gross Margin
S2Medical AB (publ)

89.5%
Current
91%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
89.5%
=
Gross Profit
9.5m
/
Revenue
10.6m

Gross Margin Across Competitors

Country SE
Market Cap 7.1m SEK
Gross Margin
89%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.9B CHF
Gross Margin
55%
Country DK
Market Cap 200.9B DKK
Gross Margin
68%
Country US
Market Cap 16.9B USD
Gross Margin
70%
Country KR
Market Cap 9.9T KRW
Gross Margin
15%
Country CA
Market Cap 6.9B USD
Gross Margin
61%
Country CN
Market Cap 48.6B CNY
Gross Margin
73%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Country US
Market Cap 6.1B USD
Gross Margin
47%
Country UK
Market Cap 4.8B GBP
Gross Margin
56%
No Stocks Found

S2Medical AB (publ)
Glance View

Market Cap
7.1m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0322 SEK
Undervaluation 74%
Intrinsic Value
Price
S

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
89.5%
=
Gross Profit
9.5m
/
Revenue
10.6m
What is the Gross Margin of S2Medical AB (publ)?

Based on S2Medical AB (publ)'s most recent financial statements, the company has Gross Margin of 89.5%.